Study IDs HIT as 'critical component" of successful ACOs

Health IT is one "critical component" to establishing a successful accountable care organization, particularly those created by academic medical centers, according to a study published in Academic Medicine.

Researchers from Johns Hopkins University School of Medicine analyzed the first 235 Medicare ACOs established in the U.S., 20 percent of which were created at academic medical centers.

In addition to robust health IT and analytics systems, the authors identified reliable coordination of care across all types of teams and strong leadership as particularly important for academic medical centers to address when launching new ACOs.

"It's important [for academic institutions] to quickly identify areas where changes are needed," wrote Scott Berkowitz, study co-author and medical director for accountable care for Johns Hopkins Medicine, and co-author Jennifer Pahira. "There has to be an electronic [health] record system robust enough to analyze and assess quality and safety issues."

Berkowitz and Pahira say leadership needs to involve both primary care and specialty providers in planning and operations. “It’s important for academic medical centers to use their resources wisely when making the transition,” Berkowitz says. “Effective ACOs use strategies that align quality and costs from the start.”

While the first generation of ACOs are generating data that has yet to be fully processed, the authors also noted that "further study of results from Medicare-related ACO programs and commercial ACOs will help define best practices."

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.